Related Experiment Video
Updated: Jan 2, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Association between MIC-1 and Type 2 Diabetes: A Combined Analysis.
Jianan Lu1, Yue Zhang1, Xingxuan Dong1
1Department of Epidemiology and Biostatics, Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public Health, Medical College of Soochow University, 199 Ren Ai Road, Suzhou, China.
Macrophage-inhibiting cytokine-1 (MIC-1) levels are significantly elevated in type 2 diabetes mellitus (T2DM) patients. This bioinformatics analysis confirms MIC-1 as a potential biomarker for T2DM, highlighting its increased expression in blood samples.
Area of Science:
- Endocrinology
- Molecular Biology
- Bioinformatics
Background:
- Type 2 diabetes mellitus (T2DM) is a global health concern.
- Previous studies suggested a link between macrophage-inhibiting cytokine-1 (MIC-1) and T2DM, but findings were inconclusive.
Purpose of the Study:
- To conduct a bioinformatics analysis to clarify the association between MIC-1 and T2DM.
- To evaluate MIC-1 as a potential biomarker for T2DM.
Main Methods:
- Searched multiple databases (GEO, PubMed, Google Scholar, Web of Science) for relevant studies.
- Extracted and pooled MIC-1 expression levels from 11 GEO datasets and 3 articles.
- Compared MIC-1 expression between T2DM cases and controls.
Main Results:
- Included 421 T2DM cases and 711 controls.
- Found significantly higher MIC-1 expression in T2DM patients compared to controls (SMD = 0.54).
- MIC-1 expression was also significantly elevated in blood samples (SMD = 0.65) and showed diagnostic potential (AUC = 0.81).
Conclusions:
- MIC-1 expression levels are significantly higher in T2DM patients across multiple tissues, including blood.
- MIC-1 demonstrates potential as a diagnostic biomarker for T2DM.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications

